GSK at PEGS Europe 2026

Nov 16–19, 2026 Lisbon, Portugal ~1.5k attendees Website

GSK brings 3 presentations to PEGS Europe 2026 in Lisbon. Its program covers modelling how biparatopic antibodies engage their target and methods for customisable protein expression in CHO cells. Its interests also reach peptide drug discovery.

OrganizationPEGS Europe 2026 Attendance
GSK
London, UK
Talk
Tue Nov 17
9:00am–9:30am
Modelling Biparatopic Antibody Target Engagement and Pharmacology
Optimisation & Developability
Talk
Wed Nov 18
9:00am–9:30am
Methods and Technologies for Customisable Protein Expression in CHO Cells
Designing High-Performance Expression Platforms
Chair
Thu Nov 19
10:44am–10:45am
Chairperson's Remarks
Novel Peptide Drug Discovery

Explore the full PEGS Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Lisbon. Leave your work email and we’ll be in touch.

Privacy

Download the full PEGS Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from GSK

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by PEGS Europe or its organizers. Submit a correction